Macrophage Activation Syndrome
What's New
Last Posted: Jul 05, 2024
- Enrichment of Rare Variants of Hemophagocytic Lymphohistiocytosis Genes in Systemic Juvenile Idiopathic Arthritis.
Mariana Correia Marques, et al. Arthritis & rheumatology (Hoboken, N.J.) 2024 0 - Early identification of macrophage activation syndrome secondary to systemic lupus erythematosus with machine learning.
Wenxun Lin et al. Arthritis Res Ther 2024 26(1) 92 - Adults with septic shock and extreme hyperferritinemia exhibit pathogenic immune variation.
Kernan Kate F, et al. Genes and immunity 2018 0 (6) 520-526 - Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis.
Eloseily Esraa M, et al. Arthritis & rheumatology (Hoboken, N.J.) 2019 0 (2) 326-334 - Emergent high fatality lung disease in systemic juvenile arthritis.
Saper Vivian E, et al. Annals of the rheumatic diseases 2019 0 (12) 1722-1731 - Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
Abplanalp Wesley Tyler, et al. JAMA cardiology 2020 0 (10) 1170-1175 - The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis.
Bami Sakshi, et al. Pediatric blood & cancer 2020 0 (11) e28581 - Recessive NLRC4-Autoinflammatory Disease Reveals an Ulcerative Colitis Locus.
Steiner Annemarie, et al. Journal of clinical immunology 2021 0 (2) 325-335 - Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles.
Saper Vivian E, et al. Annals of the rheumatic diseases 2021 0 (3) 406-415 - Evaluation of the relationship between pentraxin 3 (PTX3) rs2305619 (281A/G) and rs1840680 (1449A/G) polymorphisms and the clinical course of COVID-19.
Kerget Ferhan, et al. Journal of medical virology 2021 0 (12) 6653-6659 - Frequency of Interleukin-6 rs1800795 (-174G/C) and rs1800797 (-597G/A) Polymorphisms in COVID-19 Patients in Turkey Who Develop Macrophage Activation Syndrome.
Kerget Ferhan, et al. Japanese journal of infectious diseases 2021 0 (6) 543-548 - Hemophagocytic Lymphohistiocytosis Gene Variants in Childhood-Onset Systemic Lupus Erythematosus With Macrophage Activation Syndrome.
Lahiry Piya, et al. The Journal of rheumatology 2022 0 (10) 1146-1151 - Role of Genetic Polymorphism Present in Macrophage Activation Syndrome Pathway in Post Mortem Biopsies of Patients with COVID-19.
Zanchettin Aline Cristina, et al. Viruses 2022 0 (8) - Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders.
Arnold Dennis D et al. Frontiers in immunology 2022 13888392 - Machine learning derivation of four computable 24-h pediatric sepsis phenotypes to facilitate enrollment in early personalized anti-inflammatory clinical trials.
Qin Yidi et al. Critical care (London, England) 2022 26(1) 128 - Effects of HLA-DRB1 alleles on susceptibility and clinical manifestations in Japanese patients with adult onset Still's disease.
Asano Tomoyuki, et al. Arthritis research & therapy 2017 0 (1) 199 - Serum amyloid A1 (SAA1) gene polymorphisms in Japanese patients with adult-onset Still's disease.
Yashiro Makiko, et al. Medicine 2018 12 (49) e13394 - Association of IRF5 polymorphisms with susceptibility to hemophagocytic lymphohistiocytosis in children.
Yanagimachi Masakatsu, et al. Journal of clinical immunology 2011 12 (6) 946-51 - Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis.
Yanagimachi Masakatsu, et al. The Journal of rheumatology 2011 4 (4) 769-74 - Macrophage activation syndrome
From NCATS Genetic and Rare Diseases Information Center
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: